Synthetic organic chemistry plays a key role in translating the discoveries from human genomics into deep biological understandings and into new and effective therapies. Genome biology has developed new tools for dissecting the genome and is shining an increasingly bright light on genome sequences, including the variation in sequences among members of the human population and its relationship to an individual's susceptibility to specific diseases. The next step is clear yet daunting - how do we exploit these advances to gain deep insights into human physiology and pathophysiology and to discover effective treatments for the major human diseases? Lay language statement: The ability to synthesize optimal small-molecule screening collections, ones that anticipate each of the phases in which chemistry plays a role in achieving the above goal, will greatly facilitate our ability to identify, optimize and manufacture small-molecule drugs that can be used to treat human disease. We plan to advance synthetic organic chemistry in ways that will allow these goals to be achieved by combining innovation and execution. We intend to innovate around a powerful three-phase strategy ("build/couple/pair") in diversity-oriented small-molecule synthesis that emanates from our CMLD community and that may have the potential to achieve the above goals. We will ensure that innovative chemical methodology, especially methods based on powerful catalysts that impart high levels of stereochemical control on reactants, is coupled directly to our strategy for library development. We will innovate in computational chemical biology to provide analysis tools that guide the use of synthetic methodology towards the target optimal screening collections. Using this approach, we feel that our CMLD community will continue to be more than the sum of its parts. This organization and synthesis strategy will together drive our activities throughout our renewal phase. We intend to execute on this plan in part by establishing a strong collaboration with the Broad Institute's team of senior, professional staff chemists. These chemists have established a diversity synthesis Production Facility and an electronic data pipeline that we intend to use in order to achieve the scaled synthesis of compounds emanating from the proposed pathways efficiently and effectively. We are strongly committed to use the innovation of the CMLD synthetic and computational chemistry to drive an implementation activity that will yield substantial quantities of pure and highly novel compounds for small molecule screening on a wide scale, and thereby to facilitate the discovery of new medicines in the future.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center (P50)
Project #
5P50GM069721-12
Application #
8331516
Study Section
Special Emphasis Panel (ZGM1-PPBC-3 (CL))
Program Officer
Fabian, Miles
Project Start
2003-09-30
Project End
2014-08-31
Budget Start
2012-09-01
Budget End
2014-08-31
Support Year
12
Fiscal Year
2012
Total Cost
$2,096,234
Indirect Cost
$623,236
Name
Broad Institute, Inc.
Department
Type
DUNS #
623544785
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Gerard, Baudouin; O'Shea, Morgan Welzel; Donckele, Etienne et al. (2014) Correction to Application of a Catalytic Asymmetric Povarov Reaction using Chiral Ureas to the Synthesis of a Tetrahydroquinoline Library. ACS Comb Sci 16:46
Over, Björn; McCarren, Patrick; Artursson, Per et al. (2014) Impact of stereospecific intramolecular hydrogen bonding on cell permeability and physicochemical properties. J Med Chem 57:2746-54
Bergonzini, Giulia; Schindler, Corinna S; Wallentin, Carl-Johan et al. (2014) Photoredox Activation and Anion Binding Catalysis in the Dual Catalytic Enantioselective Synthesis of *-Amino Esters. Chem Sci 5:
Xu, Hao; Zhang, Hu; Jacobsen, Eric N (2014) Chiral sulfinamidourea and strong Brønsted acid-cocatalyzed enantioselective Povarov reaction to access tetrahydroquinolines. Nat Protoc 9:1860-6
Wawer, Mathias J; Li, Kejie; Gustafsdottir, Sigrun M et al. (2014) Toward performance-diverse small-molecule libraries for cell-based phenotypic screening using multiplexed high-dimensional profiling. Proc Natl Acad Sci U S A 111:10911-6
Gerard, Baudouin; Lee 4th, Maurice D; Dandapani, Sivaraman et al. (2013) Synthesis of stereochemically and skeletally diverse fused ring systems from functionalized C-glycosides. J Org Chem 78:5160-71
Rajapaksa, Naomi S; McGowan, Meredeth A; Rienzo, Matthew et al. (2013) Enantioselective total synthesis of (+)-reserpine. Org Lett 15:706-9
Lalonde, Mathieu P; McGowan, Meredeth A; Rajapaksa, Naomi S et al. (2013) Enantioselective formal aza-Diels-Alder reactions of enones with cyclic imines catalyzed by primary aminothioureas. J Am Chem Soc 135:1891-4
Wang, Yikai; Jimenez, Miguel; Sheehan, Patrick et al. (2013) Selective access to trisubstituted macrocyclic E- and Z-alkenes from the ring-closing metathesis of vinylsiloxanes. Org Lett 15:1218-21
Frumm, Stacey M; Fan, Zi Peng; Ross, Kenneth N et al. (2013) Selective HDAC1/HDAC2 inhibitors induce neuroblastoma differentiation. Chem Biol 20:713-25

Showing the most recent 10 out of 65 publications